LONDON, UK: Clinigen Group plc announced the disposal of its non-core UK Specials manufacturing and Aseptic compounding business to Target Healthcare Ltd for a total consideration of up to £7.75 million. The compounding business sourced and manufactured specific unlicensed medicines referred to as ‘specials’ in a range of formulations for supply across the UK market…
All posts tagged Clinigen Group
Synairgen and Clinigen sign agreement for treatment of hospitalised patients with COVID-19
SOUTHAMPTON: Synairgen plc and Clinigen Group have signed an agreement to launch a Managed Access Program for Synairgen’s inhaled formulation of interferon beta (IFN-beta), SNG001, in the UK and the EU for the treatment of hospitalised COVID-19 patients. SNG001 is an inhaled formulation of IFN-beta for direct delivery to the lungs via nebulisation. Synairgen announced…